EQUITY RESEARCH MEMO

Cristers

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

Cristers is a French pharmaceutical laboratory specializing in generic drugs and over-the-counter (OTC) products, uniquely owned by the community pharmacy cooperative La Coopérative WELCOOP. Founded in 1990 and headquartered in Lyon, the company supplies French pharmacies with a broad portfolio covering major therapeutic areas including cardiology, neurology, diabetology, and oncology. As a privately held entity, Cristers benefits from a stable ownership structure aligned with its pharmacy customer base, enabling long-term strategic focus on affordable medication access. Its position as a cooperative-owned generic player differentiates it from multinational competitors, fostering loyalty among independent pharmacies.

Upcoming Catalysts (preview)

  • Q3 2026Launch of new generic drugs in high-demand therapeutic categories70% success
  • Q4 2026Expansion of OTC product line to capture growing self-care market60% success
  • Q1 2027Potential strategic partnership or acquisition to broaden portfolio50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)